Drug Discovery

Can Miricorilant Revolutionize MASH Treatment in Trials?
Research & Development Can Miricorilant Revolutionize MASH Treatment in Trials?

In the realm of liver disease research, metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease also known as metabolic dysfunction-associated steatotic liver disease (MASLD), stands as a formidable challenge with potentially devastating consequences. Characterized by

FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata
Research & Development FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata

Imagine waking up each day to find more hair on your pillow than on your scalp, a stark reminder of an unseen battle within your body that strips away confidence. Alopecia areata (AA), an autoimmune condition, affects nearly 700,000 individuals in the United States, causing unpredictable hair loss

Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?
Research & Development Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of innovative technologies for neurological disorders. Today, we’re diving into the recent clinical trial results from Praxis Precision Medicines

Proteins Prove More Stable Than Previously Believed
Research & Development Proteins Prove More Stable Than Previously Believed

In a stunning turn of events, a transformative study has shattered long-standing assumptions about the fragility of proteins, revealing them to be far more resilient than the scientific community ever imagined, fundamentally changing our understanding of biological structures. Published in Science

Can SGX945 Revolutionize Behçet's Disease Treatment?
Research & Development Can SGX945 Revolutionize Behçet's Disease Treatment?

In the realm of rare diseases, Behçet's Disease stands out as a particularly challenging condition, marked by painful recurrent oral and skin ulcers that severely impact quality of life, leaving patients with limited treatment options for years. Often, they grapple with therapies that offer only

AI Discovers New Lipid-Lowering Effects in Approved Drugs
Tech & Innovation AI Discovers New Lipid-Lowering Effects in Approved Drugs

Imagine a world where millions of people struggle with high cholesterol, a silent threat that fuels heart disease, yet many cannot tolerate standard treatments like statins due to side effects or poor response, leaving them at risk. This pressing challenge affects countless lives, with

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later